<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previous studies suggested that <z:chebi fb="9" ids="16796">melatonin</z:chebi> improves sleep in insomniac patients with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To assess the efficacy of <z:chebi fb="9" ids="16796">melatonin</z:chebi>, a randomized placebo-controlled study was conducted in 8 children with <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> with idiopathic <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0100785'>insomnia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>After a 1-week baseline period, patients received, depending on age, either <z:chebi fb="9" ids="16796">melatonin</z:chebi> 5 or 2.5 mg, or placebo, followed by 4 weeks of open treatment </plain></SENT>
<SENT sid="3" pm="."><plain>Parents recorded lights off time, sleep <z:hpo ids='HP_0003674'>onset</z:hpo> time, wake-up time, and <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> in a diary </plain></SENT>
<SENT sid="4" pm="."><plain>Salivary <z:chebi fb="9" ids="16796">melatonin</z:chebi> levels were measured at baseline and the last evening of the fourth treatment week </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="9" ids="16796">Melatonin</z:chebi> significantly advanced sleep <z:hpo ids='HP_0003674'>onset</z:hpo> by 28 minutes, decreased sleep latency by 32 minutes, increased total sleep time by 56 minutes, reduced the number of nights with wakes from 3.1 to 1.6 nights a week, and increased endogenous salivary <z:chebi fb="9" ids="16796">melatonin</z:chebi> levels </plain></SENT>
<SENT sid="6" pm="."><plain>Parents were satisfied with these results </plain></SENT>
<SENT sid="7" pm="."><plain>Indications that <z:chebi fb="9" ids="16796">melatonin</z:chebi> dose in <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> patients should be low, are discussed </plain></SENT>
</text></document>